All Sentar Pharmaceuticals articles
-
ArticleSEC charges pharma CEO, 2 companies with offering fraud
The Securities and Exchange Commission charged Paul Edalat and two pharmaceuticals companies he controlled—Sentar and Vivera—with engaging in a fraudulent investment scheme.